Abstract:Introduction: Retinopathy of prematurity (ROP) is a retinal vascular developmental disease associated with risks factors such as supplementary oxygen use or low birth weight/early gestational age. Multiple studies have reported associations between ROP and systemic inflammation. In this study, we investigated serum cytokines associated with ROP development and severity and assessed their applicability as potential biomarkers of ROP. Methods: This prospective study was conducted at an institutional referral center between 2019 and 2021. To measure the serum levels of 40 inflammatory cytokines in eligible premature patients, we collected their serum samples during the enrollment of patients or the intravitreal injection of anti–vascular endothelial growth factor (VEGF) agents and after 2 and 4 weeks. Results: Fifty patients were enrolled. In patients with type 1 ROP who received anti-VEGF agents ( n = 22), the levels of serum intercellular adhesion molecule-1 decreased significantly ( p < 0.05) at 4 weeks compared with the baseline level, whereas those of serum granulocyte–macrophage colony-stimulating factor increased significantly ( p < 0.05). In patients with ROP who did not require any treatment ( n = 14), no significant change was noted in the level of any of the 40 inflammatory cytokines. In control infants without ROP ( n = 14), the serum levels of tumor necrosis factor-α, interleukin (IL)-15, and IL-12p40 increased significantly ( p < 0.05) at 4 weeks. The changes in the levels of serum inflammatory cytokines did not vary significantly among the aforementioned three groups. A generalized estimating equation indicated that zone 1 ROP, stage 3 ROP, older postmenstrual age, respiratory distress syndrome, necrotizing enterocolitis, and sepsis were associated with the changes in serum cytokine levels. Conclusions: Although significant changes (compared with baseline) were observed in the serum levels of certain inflammatory cytokines in patients with type 1 ROP and infants without ROP, no significant difference in cytokine level fluctuations were noted among the three groups. Changes in serum inflammatory cytokine levels may not predict ROP development or severity. Additional comprehensive studies are warranted to establish their definitive role and significance in ROP, emphasizing the need for continued research in this area.

The Relationship Between Cytokines Serum Levels at Postnatal 4-6 Weeks and Retinopathy of Prematurity

Association of serum levels of inflammatory cytokines with retinopathy of prematurity in preterm infants

Plasma Levels of Amino Acids and Derivatives in Retinopathy of Prematurity.

A Good Study about Early Predictive Biomarkers in Severe Retinopathy of Prematurity

Progress in the study of association between hematological indicators and retinopathy of prematurity (Review)

Analysis of risk factors of retinopathy of prematurity

Early Risk Factors for Retinopathy of Prematurity in Very and Extremely Preterm Chinese Neonates

Analysis of Factors of Threshold Retinopathy of Prematurity

Incidence and Risk Factor Analysis of Retinopathy of Prematurity

Analysis of factors of spontaneous regression of prematurity retinopathy

Predictive role of systemic immune-inflammation index and neutrophil/lymphocyte ratio values in infants with retinopathy of prematurity

Predicting Retinopathy of Prematurity Risk Using Plasma Levels of Insulin-like Growth Factor 1 (IGF1), Tumor Necrosis Factor-Alpha (TNF-Alpha), and Neonatal Parameters

The association between serum 25-hydroxyvitamin D levels and retinopathy of prematurity in preterm infants

[Evaluation of Risk Factors for Retinopathy of Prematurity].

Analysis of 218 cases of retinopathy of prematurity

The Prognostic Value Of Lymphocyte-To-Monocyte Ratio In Retinopathy Of Prematurity

Biomarkers in retinopathy of prematurity: a systematic review and meta-analysis

Serum levels of cytokines in infants treated with conbercept for retinopathy of prematurity

Targeted Blood Metabolomic Study On Retinopathy Of Prematurity

Analysis of clinical features and prognosis of 107 cases of retinopathy of prematurity

Correlation Between Apelin and VEGF Levels in Retinopathy of Prematurity: a Matched Case–control Study